Consolidated Statement Of Income

Chiome Bioscience Inc. - Filing #7373572

Concept 2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2023-01-01 to
2023-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
2022-01-01 to
2022-09-30
Consolidated statement of income
Statement of income
Net sales
JPY
524,023,000 JPY
524,023,000 JPY
JPY
524,023,000 JPY
JPY
JPY
433,694,000 JPY
433,694,000 JPY
433,694,000 JPY
Cost of sales
216,931,000 JPY
198,703,000 JPY
Operating expenses
Selling, general and administrative expenses
1,212,405,000 JPY
1,274,320,000 JPY
Other
409,157,000 JPY
357,902,000 JPY
Operating expenses
Gross profit (loss)
307,091,000 JPY
234,990,000 JPY
Operating profit (loss)
-409,157,000 JPY
-496,156,000 JPY
307,091,000 JPY
-803,247,000 JPY
-905,313,000 JPY
-357,902,000 JPY
-916,417,000 JPY
234,990,000 JPY
-1,039,329,000 JPY
-681,426,000 JPY
Net sales
Ordinary profit (loss)
-916,239,000 JPY
-1,029,779,000 JPY
Operating expenses
Research and development expenses
803,247,000 JPY
916,417,000 JPY
Extraordinary income
1,545,000 JPY
5,977,000 JPY
Cost of sales
Non-operating income
702,000 JPY
16,230,000 JPY
Interest income
17,000 JPY
19,000 JPY
Selling, general and administrative expenses
Non-operating income
Other
432,000 JPY
210,000 JPY
Non-operating expenses
Interest expenses
1,481,000 JPY
980,000 JPY
Other
655,000 JPY
286,000 JPY
Non-operating expenses
11,627,000 JPY
6,680,000 JPY
Share issuance costs
1,785,000 JPY
2,393,000 JPY
Extraordinary losses
14,000 JPY
JPY
Gross profit
Profit (loss) before income taxes
-914,707,000 JPY
-1,023,801,000 JPY
Extraordinary income
Gain on sale of non-current assets
119,000 JPY
JPY
Income taxes - current
3,757,000 JPY
3,757,000 JPY
Extraordinary losses
Loss on sale of non-current assets
14,000 JPY
JPY
Income taxes
3,757,000 JPY
3,757,000 JPY
Profit (loss)
-918,465,000 JPY
-1,027,559,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.